Balancing cyclosporine A nephrotoxicity and rejection late after adult liver transplantation.
Paul
A
A
Toronto Hospital, University of Toronto, Ontario, Canada.
Levy
G A
GA
Greig
P D
PD
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D003404:Creatinine; D008775:Methylprednisolone